AXZYB 1MG TAB

AXZYB 1MG TAB is a prescription medication that contains 1mg of Axitinib, a tyrosine kinase inhibitor used to treat certain types of cancer, including renal cell carcinoma and pancreatic neuroendocrine tumors. It is available in tablet form.

Composition:

AXZYB 1MG TAB contains 1mg of Axitinib, a white to off-white crystalline powder.

Mechanism of Action:

Axitinib works by:

• Inhibiting the activity of tyrosine kinases, which are enzymes that play a key role in the growth and proliferation of cancer cells
• Preventing the activation of downstream signaling pathways that promote cell growth and survival
• Inducing apoptosis (cell death) in cancer cells

Indication:

AXZYB 1MG TAB is indicated for:

• Treatment of advanced renal cell carcinoma (RCC) in patients who have received prior treatment with a VEGF receptor tyrosine kinase inhibitor
• Treatment of advanced pancreatic neuroendocrine tumors (pNET) in patients who have received prior treatment with a somatostatin analog

Dosage:

The recommended dosage of AXZYB 1MG TAB is:

• 5mg orally twice daily, with or without food
• Dose adjustments may be necessary based on patient response and toxicity

Side Effects:

Common side effects of AXZYB 1MG TAB may include:

• Fatigue
• Diarrhea
• Hypertension
• Nausea and vomiting
• Increased risk of bleeding
• Increased risk of liver dysfunction
• Skin rash

Recommendation:

AXZYB 1MG TAB should only be used under the guidance of a healthcare provider. Patients receiving AXZYB 1MG TAB treatment should be closely monitored for side effects and potential complications.

Important Note:

• AXZYB 1MG TAB is a potent medication that can cause serious side effects, including bleeding and liver dysfunction. Patients should be closely monitored for these side effects.
• Patients with a history of severe allergic reactions to axitinib or other tyrosine kinase inhibitors should not receive AXZYB 1MG TAB.
• Patients with a history of severe kidney disease or severe liver disease should be closely monitored while receiving AXZYB 1MG TAB.

Special Precautions:

• Patients with a history of bleeding disorders or pre-existing bleeding tendencies should be closely monitored while receiving AXZYB 1MG TAB.
• Patients with a history of liver disease or pre-existing liver dysfunction should be closely monitored while receiving AXZYB 1MG TAB.
• Patients taking concomitant medications that may interact with axitinib, such as warfarin, should be closely monitored for bleeding and liver dysfunction.

It is important to note that the dosage and administration of AXZYB 1MG TAB may vary depending on the patient’s individual needs and medical history. It is recommended that patients consult their healthcare provider before taking this medication.